Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maiva Pharma operates a USFDA-, EU GMP-, ANVISA-, Health Canada-, PIC/S-, and WHO-GMP-approved facility for sterile injectables. It has over two decades of experience supplying regulated markets with high-quality sterile solutions in vials/ampoules/bottles and lyophilized forms. The company has more than 75 commercial programs/products serving over forty customers globally. Recent funding will expand capacity to pre-filled syringes, cartridges, bags, oncology/hormonal injectables.
No clinical trial results are published since the company does not develop proprietary drugs but manufactures for clients.
Owns at least nineteen ANDA approvals for the US market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maiva Pharma.